Oral administration of probiotic Lactobacillus rhamnosus GG (LGG) augmented the anti-tumor responses to anti-PD-1 in colon cancer model in a cGAS-STING-dependent way (115). The gene discussed is PDCD1; the disease is colonic neoplasm.